Page 1

CareDx Reports 77 % Revenue Growth for Second Quarter of 2021 and Increases Full Year Revenue Guidance investors.caredxinc.com/news-releases/news-release-details/caredx-reports-77-revenue-growth-second-quarter-2021-and Jul 29 , 2021 SOUTH SAN FRANCISCO , Calif . , July 29 , 2021 ( GLOBE NEWSWIRE ) -- CareDx , Inc. ( Nasdaq : CDNA ) , a leading precision medicine company focused on the discovery , development , and commercialization of clinically differentiated , high - value healthcare solutions for transplant patients and caregivers , today reported financial results for the second quarter ended June 30 , 2021 . Recent Highlights : • Achieved total revenue of $ 74.2 million for the three months ended June 30 , 2021 , increasing 77 % year - over - year • Total AlloSure and AlloMap patient results provided in the quarter were approximately 37,400 , which includes approximately 6,600 AlloSure Heart patient results • As of June 30 , 2021 , over 65 U.S. - based transplant centers have adopted an AlloSure Kidney testing protocol . In addition , TX Connect now manages more than 29,000 transplant referrals to over 50 transplant centers from more than 800 dialysis centers and community nephrology practices • Presented positive data from first 1,000 patients from KOAR Study demonstrating higher 1 year graft survival and reduction in biopsies through ARTS surveillance " With another record quarter , we continue to lead the transformation of the transplant patient journey with our innovative and patient focused offerings , " said Reg Seeto , President and Chief Executive Officer of CareDx . " We have become the transplant partner of choice by bringing industry leading service offerings with AlloSure and AlloMap to the clinic , as well as leading innovation with our multimodal platforms ( HeartCare , KidneyCare ) , while we remain focused on the patient journey . " Second Quarter 2021 Financial Results Revenue for the three months ended June 30 , 2021 was $ 74.2 million , an increase of 77 % compared with $ 41.8 million in the second quarter of 2020. Testing services revenue for the second quarter was $ 64.9 million , compared with $ 36.3 million in the same period of 2020 . Product revenue in the three months ended June 30 , 2021 was $ 6.9 million , compared to $ 3.3 million in the same period of 2020. Digital and other revenue for the second quarter of 2021 was $ 2.4 million . 1/10